References
- Giuliano FA, Leriche A, Jaudinot EO, et al. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology. 2004;64:1196–1201.
- Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54–61.
- Montorsi F, Zanoni M, Salonia A, et al. Erectile dysfunction. Aging Male. 2001;4:74–82.
- Maiorino MI, Bellastella G, Esposito K. Diabetes and sexual dysfunction: current perspectives. Diabetes Metab Syndr Obes. 2014;7:95–105.
- Nakanishi S, Yamane K, Kamei N, et al. Erectile dysfunction is strongly linked with decreased libido in diabetic men. Aging Male. 2004;7:113–119.
- Canguven O, Talib RA, El Ansari W, et al. Vitamin D treatment improves levels of sexual hormones, metabolic parameters and erectile function in middle-aged vitamin D deficient men. Aging Male. 2017;20:9–16.
- Francis SH, Corbin JD. PDE5 inhibitors: targeting erectile dysfunction in diabetics. Curr Opin Pharmacol. 2011;11:683–688.
- Mulcahy JJ. Penile prosthesis infection: progress in prevention and treatment. Curr Urol Rep. 2010;11:400–404.
- Gross MS, Phillips EA, Carrasquillo RJ, et al. Multicenter investigation of the micro-organisms involved in penile prosthesis infection: an analysis of the efficacy of the AUA and EAU guidelines for penile prosthesis prophylaxis. J Sex Med. 2017;14:455–463.
- Skyler JS, Bergenstal R, Bonow RO, American Diabetes A, American College of Cardiology F, American Heart A, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009;32:187–192.
- Bener A, Zirie M, Janahi IM, et al. Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar. Diabetes Res Clin Pract. 2009;84:99–106.
- Bishop JR, Moul JW, Sihelnik SA, et al. Use of glycosylated hemoglobin to identify diabetics at high risk for penile periprosthetic infections. J Urol. 1992;147:386–388.
- Wilson SK, Carson CC, Cleves MA, et al. Quantifying risk of penile prosthesis infection with elevated glycosylated hemoglobin. J Urol. 1998;159:1537–1539; discussion 9–40.
- Habous M, Tal R, Soliman T, et al. Defining a Hba1c value that predicts increased risk of penile implant infection. BJU Int. 2017;121:293–300.
- Milbank AJ, Montague DK, Angermeier KW, et al. Mechanical failure of the American medical systems ultrex inflatable penile prosthesis: before and after 1993 structural modification. J Urol. 2002;167:2502.
- Bener A, Al-Ansari A, Al-Hamaq AO, et al. Prevalence of erectile dysfunction among hypertensive and nonhypertensive Qatari men. Medicina (Kaunas). 2007;43:870–878.
- Al Naimi A, Majzoub AA, Talib RA, et al. Erectile dysfunction in Qatar: prevalence and risk factors in 1,052 participants-a pilot study. Sex Med. 2014;2:91–95.
- Katz DJ, Stember DS, Nelson CJ, et al. Perioperative prevention of penile prosthesis infection: practice patterns among surgeons of SMSNA and ISSM. J Sex Med. 2012;9:1705–1712; quiz 712–714.
- Madbouly K, AlHajeri D, Habous M, et al. Association of the modified frailty index with adverse outcomes after penile prosthesis implantation. Aging Male. 2017;20:119–124.
- Mandava SH, Serefoglu EC, Freier MT, et al. Infection retardant coated inflatable penile prostheses decrease the incidence of infection: a systematic review and meta-analysis. J Urol. 2012;188:1855–1860.
- Onyeji IC, Sui W, Pagano MJ, et al. Impact of surgeon case volume on reoperation rates after inflatable penile prosthesis surgery. J Urol. 2017;197:223–229.
- Jarow JP. Risk factors for penile prosthetic infection. J Urol. 1996;156:402–404.
- Levine LA, Becher E, Bella A, et al. Penile prosthesis surgery: current recommendations from the international consultation on sexual medicine. J Sex Med. 2016;13:489–518.
- Cakan M, Demirel F, Karabacak O, et al. Risk factors for penile prosthetic infection. Int Urol Nephrol. 2003;35:209–213.
- Henry GD, Kansal NS, Callaway M, et al. Centers of excellence concept and penile prostheses: an outcome analysis. J Urol. 2009;181:1264–1268.
- Lotan Y, Roehrborn CG, McConnell JD, et al. Factors influencing the outcomes of penile prosthesis surgery at a teaching institution. Urology. 2003;62:918–921.
- Wolf JS Jr, Bennett CJ, Dmochowski RR, Urologic Surgery Antimicrobial Prophylaxis Best Practice Policy P, et al. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol. 2008;179:1379–1390.
- Mulcahy JJ, Carson CC III. Long-term infection rates in diabetic patients implanted with antibiotic-impregnated versus nonimpregnated inflatable penile prostheses: 7-year outcomes. Eur Urol. 2011;60:167–172.
- Carson CC III, Mulcahy JJ, Harsch MR. Long-term infection outcomes after original antibiotic impregnated inflatable penile prosthesis implants: up to 7.7 years of followup. J Urol. 2011;185:614–618.